$AEYE
AUDIOEYE INC

2017 Q1 Form 10-Q Financial Statement

#000114420417027028 Filed on May 15, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1
Revenue $434.5K $124.7K
YoY Change 248.44% 23.42%
Cost Of Revenue $341.0K $294.8K
YoY Change 15.68% -36.21%
Gross Profit $93.47K -$170.1K
YoY Change -154.95% -52.89%
Gross Profit Margin 21.51% -136.41%
Selling, General & Admin $1.017M $594.4K
YoY Change 71.17% -75.11%
% of Gross Profit 1088.54%
Research & Development $44.70K $85.62K
YoY Change -47.79% -39.83%
% of Gross Profit 47.83%
Depreciation & Amortization $447.00 $0.00
YoY Change -100.0%
% of Gross Profit 0.48%
Operating Expenses $1.208M $818.5K
YoY Change 47.53% -69.27%
Operating Profit -$1.114M -$988.7K
YoY Change 12.69% -67.32%
Interest Expense $164.00 -$110.2K
YoY Change -100.15% -3645.7%
% of Operating Profit
Other Income/Expense, Net $310.9K -$3.522M
YoY Change -108.83% -113464.15%
Pretax Income -$800.0K -$4.510M
YoY Change -82.26% 49.34%
Income Tax
% Of Pretax Income
Net Earnings -$803.2K -$4.511M
YoY Change -82.19% 49.28%
Net Earnings / Revenue -184.85% -3617.32%
Basic Earnings Per Share
Diluted Earnings Per Share -$178.6K -$1.379M
COMMON SHARES
Basic Shares Outstanding 112.0M shares 81.72M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $780.0K $1.130M
YoY Change -30.97% 37.8%
Cash & Equivalents $783.7K $1.080M
Short-Term Investments $0.00 $50.00K
Other Short-Term Assets $10.00K $40.00K
YoY Change -75.0% -71.43%
Inventory
Prepaid Expenses
Receivables $57.60K $19.28K
Other Receivables $0.00 $0.00
Total Short-Term Assets $860.0K $1.190M
YoY Change -27.73% 19.0%
LONG-TERM ASSETS
Property, Plant & Equipment $5.289K
YoY Change
Goodwill $700.5K
YoY Change
Intangibles $2.738M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.920M $3.444M
YoY Change -15.21% -6.68%
TOTAL ASSETS
Total Short-Term Assets $860.0K $1.190M
Total Long-Term Assets $2.920M $3.444M
Total Assets $3.780M $4.634M
YoY Change -18.42% -1.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $260.0K $270.0K
YoY Change -3.7% -47.06%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $20.00K $20.00K
YoY Change 0.0% 0.0%
Total Short-Term Liabilities $3.930M $4.434M
YoY Change -11.36% 691.7%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $1.960M
YoY Change -100.0% 4800.0%
Other Long-Term Liabilities $10.00K
YoY Change
Total Long-Term Liabilities $10.00K $1.960M
YoY Change -99.49% 4800.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.930M $4.434M
Total Long-Term Liabilities $10.00K $1.960M
Total Liabilities $3.950M $6.397M
YoY Change -38.25% 948.71%
SHAREHOLDERS EQUITY
Retained Earnings -$34.62M -$28.75M
YoY Change 20.42%
Common Stock $817.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $623.0K
YoY Change
Treasury Stock Shares
Shareholders Equity -$164.3K -$1.763M
YoY Change
Total Liabilities & Shareholders Equity $3.781M $4.634M
YoY Change -18.4% -1.2%

Cashflow Statement

Concept 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income -$803.2K -$4.511M
YoY Change -82.19% 49.28%
Depreciation, Depletion And Amortization $447.00 $0.00
YoY Change -100.0%
Cash From Operating Activities -$613.0K -$560.0K
YoY Change 9.47% -76.86%
INVESTING ACTIVITIES
Capital Expenditures $5.736K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$56.71K -$40.00K
YoY Change 41.77% 33.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $50.00K $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $44.00K -10.00K
YoY Change -540.0% -100.65%
NET CHANGE
Cash From Operating Activities -$613.0K -560.0K
Cash From Investing Activities -$56.71K -40.00K
Cash From Financing Activities $44.00K -10.00K
Net Change In Cash -$625.8K -610.0K
YoY Change 2.58% -32.97%
FREE CASH FLOW
Cash From Operating Activities -$613.0K -$560.0K
Capital Expenditures $5.736K $0.00
Free Cash Flow -$618.8K -$560.0K
YoY Change 10.5% -76.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
34455786 USD
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
34124181 USD
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-34621257 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33818061 USD
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
-164349 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
307237 USD
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3781147 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4488600 USD
CY2017Q1 us-gaap Cash
Cash
783664 USD
CY2016Q4 us-gaap Cash
Cash
1409418 USD
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
57599 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44645 USD
CY2017Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1200 USD
CY2016Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1200 USD
CY2017Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
456444 USD
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
386485 USD
CY2017Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3173915 USD
CY2016Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3478626 USD
CY2017Q1 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
2811 USD
CY2016Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
207 USD
CY2017Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
11461 USD
CY2016Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
14450 USD
CY2016Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-3412059 USD
CY2017Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
310773 USD
CY2016Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-110165 USD
CY2017Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
164 USD
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3522224 USD
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
310937 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-4510876 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-803196 USD
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
81717154 shares
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
111884024 shares
CY2016Q1 us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
21875 USD
CY2017Q1 us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
20000 USD
CY2016Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4532751 USD
CY2017Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-823196 USD
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
124702 USD
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
434507 USD
CY2017Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
17875 USD
CY2017Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-6062 USD
CY2017Q1 aeye Adjustments To Additional Paid In Capital Warrant And Options Issued For Services
AdjustmentsToAdditionalPaidInCapitalWarrantAndOptionsIssuedForServices
211464 USD
CY2017Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
58333 USD
CY2016Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
138538 USD
CY2017Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
145488 USD
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
215778 USD
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
211464 USD
CY2016Q1 aeye Common Stock Issuance Costs
CommonStockIssuanceCosts
0 USD
CY2017Q1 aeye Common Stock Issuance Costs
CommonStockIssuanceCosts
17875 USD
CY2016Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
46141 USD
CY2017Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3459 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12954 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
58459 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11853 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-17764 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
51750 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-564700 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-613048 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-36067 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-56706 USD
CY2016Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-6000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
44000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-606767 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-625754 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1687257 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1409418 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1080490 USD
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
783664 USD
CY2017Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-5871 USD
CY2016Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
0 USD
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
89506 USD
CY2016Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
36067 USD
CY2017Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
50970 USD
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
69959 USD
CY2016Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2017Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2017Q1 us-gaap Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
385 USD
CY2016Q1 us-gaap Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
0 USD
CY2017Q1 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-6000 USD
CY2016Q1 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-6000 USD
CY2017Q1 us-gaap Interest Paid
InterestPaid
0 USD
CY2016Q1 us-gaap Interest Paid
InterestPaid
0 USD
CY2017Q1 us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
6062 USD
CY2016Q1 us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
0 USD
CY2016Q3 us-gaap Litigation Settlement Amount
LitigationSettlementAmount
1525000 USD
CY2016Q3 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
100000 USD
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
111994142 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
111512001 shares
CY2017Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2151069 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2006028 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2313249 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2219178 USD
CY2017Q1 aeye Due To Related Party For Unreimbursed Travel Related Expenses
DueToRelatedPartyForUnreimbursedTravelRelatedExpenses
16000 USD
CY2017Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25925 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25478 USD
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5289 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 USD
CY2017Q1 us-gaap Depreciation
Depreciation
447 USD
CY2016Q1 us-gaap Depreciation
Depreciation
0 USD
CY2017Q1 aeye Working Capital Amount
WorkingCapitalAmount
3077883 USD
CY2017Q1 aeye Working Capital
WorkingCapital
96032 USD
CY2017Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
50000 USD
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
160000 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
160000 shares
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
160000 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
160000 shares
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
111994142 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
111512001 shares
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5736 USD
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2017Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <u><font style="BACKGROUND: transparent; FONT-SIZE: 10pt">Use of Estimates</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company&#8217;s stock, stock-based compensation, fair values relating to derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q4 aeye Due To Related Party For Unreimbursed Travel Related Expenses
DueToRelatedPartyForUnreimbursedTravelRelatedExpenses
8000 USD
CY2015Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2500000 USD
CY2015Q4 aeye Class Of Warrant Or Right Exercisable Number
ClassOfWarrantOrRightExercisableNumber
25000000 shares
CY2015Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.10
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P5Y
CY2017Q1 aeye Class Of Warrant Or Right Exercisable Number
ClassOfWarrantOrRightExercisableNumber
1792000 shares
CY2017Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.25
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P5Y
CY2015Q4 aeye Common Stock Issuance Price Per Share
CommonStockIssuancePricePerShare
0.10
CY2015Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.10
CY2016Q1 us-gaap Fair Value Assumptions Weighted Average Volatility Rate
FairValueAssumptionsWeightedAverageVolatilityRate
1.02 pure
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P5Y
CY2017Q1 aeye Common Stock Issuance Price Per Share
CommonStockIssuancePricePerShare
0.25
CY2016 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
280777 USD
CY2017Q1 us-gaap Share Price
SharePrice
0.13
CY2017Q1 us-gaap Fair Value Assumptions Weighted Average Volatility Rate
FairValueAssumptionsWeightedAverageVolatilityRate
1.720 pure
CY2017Q1 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0193 pure
CY2017Q1 us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
3173915 USD
CY2017Q1 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
310773 USD
CY2017Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
357143 shares
CY2017Q1 aeye Stock Issued During Period Shares Warrants Exercised
StockIssuedDuringPeriodSharesWarrantsExercised
40000 shares
CY2017Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
50000 USD
CY2017Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.25
CY2017Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
41666 shares
CY2017Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
6625 USD
CY2017Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
41666 shares
CY2017Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
5333 USD
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
25931207 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
25731207 shares
CY2017Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000 USD
CY2016Q1 aeye Restricted Stock Units Issued In Payment Of Accrued Compensation
RestrictedStockUnitsIssuedInPaymentOfAccruedCompensation
0 USD
CY2017Q1 aeye Restricted Stock Units Issued In Payment Of Accrued Compensation
RestrictedStockUnitsIssuedInPaymentOfAccruedCompensation
58333 USD
CY2017Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
6062 USD

Files In Submission

Name View Source Status
0001144204-17-027028-index-headers.html Edgar Link pending
0001144204-17-027028-index.html Edgar Link pending
0001144204-17-027028.txt Edgar Link pending
0001144204-17-027028-xbrl.zip Edgar Link pending
aeye-20170331.xml Edgar Link completed
aeye-20170331.xsd Edgar Link pending
aeye-20170331_cal.xml Edgar Link unprocessable
aeye-20170331_def.xml Edgar Link unprocessable
aeye-20170331_lab.xml Edgar Link unprocessable
aeye-20170331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pg1img1_10q.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v465826_10q.htm Edgar Link pending
v465826_ex31-1.htm Edgar Link pending
v465826_ex32-1.htm Edgar Link pending